Scleroderma, Systemic: all 695 studies
Page 2 of 7. Open to participants first (224), then studies with results posted, then the rest; newest registration first within each.
- Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune DiseasesNot yet recruitingNCT06970951Early Phase 1
- Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic SclerosisRecruitingNCT06954597Phase 2
- Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.RecruitingNCT06947473Phase 1/2
- CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAHRecruitingNCT06947460Phase 1/2
- CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune DiseasesRecruitingNCT06941129Phase 1
- Safety and Efficacy of Baricitinib on Skin Tightening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With MethotrexateRecruitingNCT06936215Phase 3
- A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune DiseaseRecruitingNCT06925542Phase 1
- DERMATOMICS: Identifying Regulators of Skin HomeostasisRecruitingNCT06894654
- Mesenchymal Stem Cells Infusion in Patients With Autoimmune DiseasesEnrolling by invitationNCT06888973Phase 1/2
- Safety Study of CC312 in Autoimmune Disease PatientsRecruitingNCT06888960Early Phase 1
- Clinical Study of CD7 CAR-T Cells for Relapsed/refractory Autoimmune DiseasesNot yet recruitingNCT06871644Not applicable
- Home-Based Clinical Management of Cardiac Complications in Systemic SclerosisRecruitingNCT06865118
- Chester Step Test: is It Effective in Scleroderma Patients?Not yet recruitingNCT06859567Not applicable
- Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune DiseasesRecruitingNCT06828042Phase 1/2
- A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic SclerosisRecruitingNCT06827977Phase 2
- CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)RecruitingNCT06822881Phase 1
- Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined With Immunosuppressants in the Treatment of Refractory Autoimmune DiseasesNot yet recruitingNCT06821659Phase 1/2
- BCMA-CD19 CAR-T Therapy for Refractory Autoimmune DiseasesRecruitingNCT06794008Phase 2
- Ultrasound and Electrophysiology Study of Hand in Systemic Sclerosis Patients and Contributors of Hand DysfunctionNot yet recruitingNCT06776575
- Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune DiseasesRecruitingNCT06775912Early Phase 1
- Relationship Between Pelvic Floor Dysfunctions and Sexual Dysfunction in Female Patients with Systemic SclerosisNot yet recruitingNCT06769399
- A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)RecruitingNCT06733935Phase 1/2
- Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic DiseasesRecruitingNCT06732674Not applicable
- Phase I/II Randomized Clinical Trial of Allogeneic Adipose Tissue-derived Mesenchymal Stromal Cells Systemic Infusion in Severe Systemic SclerosisNot yet recruitingNCT06722105Phase 1/2
- US Zamto-cel Autoimmune DiseasesRecruitingNCT06708845Phase 1
- Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune DiseasesRecruitingNCT06685042Phase 1/2
- Respiratory Muscle Training in SclerodermaNot yet recruitingNCT06684132Not applicable
- Ultrasonic COmparison of Salivary Glands in Autoimmune Diseases (COUGAR)Not yet recruitingNCT06680310
- The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of LifeRecruitingNCT06675344Not applicable
- Intralesional Injection of STS in Treatment of CalcinosisRecruitingNCT06672822Phase 2
- Hand ScleroDerma Lived Experience Scale in Individuals With Systemic SclerosisEnrolling by invitationNCT06658483
- Hand Disability In Systemic Sclerosis - Digital UlcersEnrolling by invitationNCT06658470
- Rare AutoImmune SElf-management Programme DevelopmentRecruitingNCT06642870
- Assessment of Serum CD25 Level in Systemic Sclerosis Patients with or Without Interstitial Lung Disease (ILD)Not yet recruitingNCT06615128
- Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune DiseasesRecruitingNCT06614270Not applicable
- Investigation of Respiratory Muscle Sarcopenia in Patients with Systemic SclerosisRecruitingNCT06598982
- Functional Performance and Biopsychosocial Characteristics in Individuals with Systemic SclerosisRecruitingNCT06594302
- ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUSRecruitingNCT06593041
- 6-minute Pegboard Ring Test in Patients with SclerodermaNot yet recruitingNCT06588959
- Nailfold Capillaroscopic Pattern Changes and Its Correlation with Interstitial Lung Disease (ILD) in Systemic Sclerosis (SSc) Patients.Not yet recruitingNCT06579651
- Respiratory Muscle Strength and Aerobic Capacity in SclerodermaRecruitingNCT06554132
- Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune DiseasesRecruitingNCT06548607Early Phase 1
- The Safety and Efficacy of Telitacicept in the Treatment of Systemic SclerosisRecruitingNCT06546540Phase 4
- Integration of Remote Monitoring in the Management of Chronic Immunosuppressive TherapyRecruitingNCT06544343Not applicable
- 89Zr-Oxine-RY_SW01 Cell Injection for the Treatment of Systemic SclerosisNot yet recruitingNCT06489652Phase 1
- Connective Tissue Massage in SclerodermaRecruitingNCT06474910Not applicable
- Chest CT Biomarkers as Prognostic Predictors in SSc-ILDEnrolling by invitationNCT06472362
- Neutrophil Extracellular Traps in Different Forms of Systemic SclerosisRecruitingNCT06462768
- Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune DisordersRecruitingNCT06434363Phase 1/2
- The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune DiseasesNot yet recruitingNCT06420154Early Phase 1
- Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune DiseasesNot yet recruitingNCT06417398Early Phase 1
- Relmacabtagene Autoleucel for the Treatment of Systemic SclerosisRecruitingNCT06414135Phase 1
- Evaluation of Patients With Systemic Sclerosis Without Specific or Associated AutoantibodiesNot yet recruitingNCT06412614
- An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune DiseaseRecruitingNCT06379646Not applicable
- A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune DiseaseEnrolling by invitationNCT06375993Phase 1
- Efficacy and Safety of Telitacicept in the Treatment of Systemic SclerosisRecruitingNCT06375005Phase 2
- Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune DiseaseRecruitingNCT06373081Not applicable
- Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune DiseasesRecruitingNCT06361745Not applicable
- Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)RecruitingNCT06350110Phase 1/2
- CAR-T Cells in Systemic B Cell Mediated Autoimmune DiseaseRecruitingNCT06347718Phase 1/2
- RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic SclerosisRecruitingNCT06328777Phase 2/3
- Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune DiseasesRecruitingNCT06316076Phase 1
- A Phase 1 Study of FT819 in B-cell Mediated Autoimmune DiseaseRecruitingNCT06308978Phase 1
- Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung DiseaseRecruitingNCT06297096Phase 3
- Renal Assessment for Early Detection of Renal Impairment in Systemic Sclerosis and Systemic Lupus Erythematosus PatientsNot yet recruitingNCT06287125
- Delving Into Participation Trends of Scleroderma Clinical TrialsNot yet recruitingNCT06264492
- Study of Diosmin for the Treatment of Digital Ulcers in Systemic SclerosisRecruitingNCT06256575Not applicable
- A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard TherapyRecruitingNCT06249438Phase 1
- Platform Clinical Study for Conquering SclerodermaRecruitingNCT06195072Phase 2
- A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung DiseaseRecruitingNCT06189495Phase 2
- Safety and Efficacy of Topical Sodium Metabisulfite for the Treatment of Calcinosis in Patients With Systemic SclerosisNot yet recruitingNCT06155578Phase 1/2
- Subcutaneous Semaglutide in Systemic SclerodermaRecruitingNCT06149260Phase 1
- Hand Function Impairment in Systemic Sclerosis: Outcomes, Mechanisms and Experience (HANDSOME)RecruitingNCT06133244
- "Pulmonary Rehabilitation Program in Patients With Interstitial Lung Disease Associated With Systemic Sclerosis"RecruitingNCT06105073
- RY_SW01 Cell Injection Therapy in Systemic SclerosisRecruitingNCT06058091Phase 1/2
- Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune DiseaseRecruitingNCT06056921Phase 1
- Evaluation of Muscle Involvement in Systemic SclerosisRecruitingNCT06051773
- Effectiveness of Tofacitinib in Systemic SclerosisRecruitingNCT06044844Phase 2
- Juvenile Systemic Sclerosis, a Retrospective Epidemiological Study on a French CohortRecruitingNCT06019234
- Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic SclerosisRecruitingNCT05989763Not applicable
- Acceptance and Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Vaccination in Systemic Sclerosis Patients Treated by Autologous Hematopoietic Stem Cell TransplantationNot yet recruitingNCT05960058
- Manufacturing of Allogeneic Adipose Tissue-derived Mesenchymal Stromal Cells for Treatment of Severe Systemic SclerosisNot yet recruitingNCT05947682Not applicable
- Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)RecruitingNCT05892614Phase 2
- A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung DiseaseRecruitingNCT05878717Phase 2/3
- Effectiveness of ESWT and PNF in Scleroderma With CalcinosisNot yet recruitingNCT05870852Not applicable
- Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune DiseasesEnrolling by invitationNCT05859997Not applicable
- Leap Motion Based Gamefication Exercises in the Individuals With Systemic SclerosisNot yet recruitingNCT05821335Not applicable
- Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung DiseaseRecruitingNCT05785065Phase 2
- Prospective Cohort of Patients With Systemic Sclerosis at Brest University Hospital With BiobankingRecruitingNCT05532865
- Evaluation of HRCT Patterns in Systemic Sclerosis-associated Interstitial Lung DiseaseRecruitingNCT05482607
- Interstitial Lung Disease Trajectories in Patients With Systemic SclerosisRecruitingNCT05345795
- Analysis of Dermal Fibroblasts and Immune Cells During Systemic SclerosisRecruitingNCT05273138
- Periodontal Health Status in Patients with Systemic SclerosisRecruitingNCT05215431Not applicable
- Efficacy of a Personalized Rehabilitation Program of Facial Involvement in Systemic SclerosisRecruitingNCT05177380Not applicable
- Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease.RecruitingNCT05168215
- ADRCs in The Treatment of Hand Dysfunction Due to SclerodermaNot yet recruitingNCT05148598Phase 3
- PET Imaging of Systemic Sclerosis Using FDG and 68Ga-DOTA-Siglec-9Enrolling by invitationNCT05108857
- What is the Optimal Follow-up for Patients With Systemic Sclerosis?Not yet recruitingNCT05103553Not applicable
- Preventive Effect of Clopidogrel on the Systemic Sclerosis Development RiskRecruitingNCT05098704Phase 2/3
- Rehabilitation Program in Patients With SclerodermaRecruitingNCT05041868Not applicable